Evidence map›Paper›PMID 41426968›Full record

ArticleSovremennye tekhnologii v meditsine2025

The Use of High-Concentration Collagen-Based Composition and Gelatin Granules as Bioinks for Extrusion 3D Bioprinting of Porous-Structured Hydrogel Constructs.

A A Kisel, E V Isaeva, E E Beketov, N V Arguchinskaya, V R Gusarova, A O Yakimova, G A Demyashkin, T S Lagoda, D S Baranovsky, I D Klabukov and 3 more

Abstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

A A KiselResearcher, Laboratory of Tissue Engineering; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia.
E V IsaevaPhD, Senior Researcher, Laboratory of Tissue Engineering; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia.
E E BeketovPhD, Director of Development Center; Mabscale LLC, 5A Highway No.4, Special Industrial and Production Economic Zone, Tolyatti, 445043, Russia.
N V ArguchinskayaJunior Researcher, Laboratory of Tissue Engineering; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia.
V R GusarovaBiologist, Laboratory of Post-Radiation Recovery, Department of Radiation Biochemistry; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia.
A O YakimovaPhD, Head of the Laboratory of Molecular and Cellular Radiobiology; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia.
G A DemyashkinMD, DSc, Head of the Pathomorphology Department; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia; Head of Histology and Immunohistochemistry Department, Institute of Translational Medicine and Biotechnology; First Moscow State Medical University named after I.M. Sechenov (Sechenov University), 8/2 Trubetskaya St., Moscow, 119991, Russia.
T S LagodaPhD, Research Laboratory Assistant, Laboratory of Tissue Engineering; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia.
D S BaranovskyMD, PhD, Head of the Biotechnology Research and Production Complex; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia; Deputy Head of the Center for Collective Use of Scientific Equipment "Radiological and Cellular Technologies"; National Medical Research Radiology Centre of the Ministry of the Russian Federation, 4 Korolev St., Obninsk, 249036, Russia.
I D KlabukovPhD, Associate Professor; Obninsk Institute for Nuclear Power Engineering - the Branch of National Research Nuclear University MEPHI, 1 Campus Territory, Obninsk, 249034, Russia; Researcher; Peoples' Friendship University of Russia named after Patrice Lumumba, 6 Miklukho-Maklaya St., Moscow, 117198, Russia; Head of Regenerative Medicine Department; National Medical Research Radiology Centre of the Ministry of the Russian Federation, 4 Korolev St., Obninsk, 249036, Russia.
S A IvanovMD, DSc, Corresponding Member of the Russian Academy of Sciences, Director; The A. Tsyb Medical Radiological Research Centre - the Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 10 Zhukov St., Obninsk, 249036, Russia; Professor of the Department of Oncology and X-ray Radiology named after V.P. Kharchenko, Medical Institute; Peoples' Friendship University of Russia named after Patrice Lumumba, 6 Miklukho-Maklaya St., Moscow, 117198, Russia.
P V ShegayMD, PhD, Head of the Center for Innovative Radiological and Regenerative Technologies; National Medical Research Radiology Centre of the Ministry of the Russian Federation, 4 Korolev St., Obninsk, 249036, Russia.
A D KaprinMD, DSc, Professor, Academician of the Russian Academy of Sciences, General Director; National Medical Research Radiology Centre of the Ministry of the Russian Federation, 4 Korolev St., Obninsk, 249036, Russia; Head of the Department of Urology and Operative Nephrology with a Course of Oncourology, Medical Institute; Peoples' Friendship University of Russia named after Patrice Lumumba, 6 Miklukho-Maklaya St., Moscow, 117198, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: Bioprinting was performed on a 3D Invivo bioprinter (Rokit, South Korea). We assessed the filament continuity during extrusion, the changes in its thickness after test printing and incubation, as well as the biodegradation of prepared scaffolds. The hydrogel cytocompatibility was studied by the proliferation of adipose-derived stem cells (ADSCs) incorporated into the scaffolds. Flow cytometry was performed to determine the immunophenotype of ADSCs. Cell proliferation in the scaffold structure was studied Results: The extrusion of the high concentration collagen-based hydrogel composition (40 mg/ml) and gelatin granules (6.25 mg/ml) during printing was stable, there was no filament breakage. When incubated in phosphate-buffered saline, the filament thickness of the hydrogel was statistically significantly higher than the scaffold thickness after printing. The degradation of the scaffolds from the hydrogel and gelatin in the solution of type I collagenase started earlier than the collagen scaffolds. The incubation in phosphate-buffered saline for 14 days resulted in less mass loss when drying the collagen scaffolds with gelatin granules. The cells isolated from human adipose tissue expressed surface markers characteristic of ADSCs. ADSCs proliferation and differentiation in chondrogenic direction were observed in both groups compared. The differences were in the spatial arrangement of the cells. In the collagen scaffolds the most cells were on the surface, while in the scaffolds from collagen and gelatin the cells were distributed throughout the whole volume. The 2 Conclusion: The present study suggested the bioink composition based on high concentration collagen (40 mg/ml) and gelatin granules (6.25 mg/ml) for bioprinting of porous-structured hydrogel constructs. The study showed hydrogel to be appropriate for printing and exhibited the properties of a porous material. The hydrogel provided the uniform distribution of ADSCs in the scaffold volume, contributing to their differentiation in the chondrogenic direction. Thus, the suggested bioink composition appears to be a promising material to be used in tissue engineering.

Indexed as

BioprintingCollagenGelatinHydrogelsPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsAdipose TissueCell ProliferationCells, CulturedHumansPorosityStem CellsCollagenGelatinHydrogels3D bioprintingADSCsbioinksscaffoldtissue engineering

Identifiers

PMID41426968
PMCPMC12715487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.